➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
Express Scripts
Baxter
Medtronic

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Medpointe Pharm Hlc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MEDPOINTE PHARM HLC, and what generic and branded alternatives to MEDPOINTE PHARM HLC drugs are available?

MEDPOINTE PHARM HLC has twenty approved drugs.



Summary for Medpointe Pharm Hlc
US Patents:0
Tradenames:18
Ingredients:17
NDAs:20

Drugs and US Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc MILPREM-200 estrogens, conjugated; meprobamate TABLET;ORAL 011045-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc MILPREM-400 estrogens, conjugated; meprobamate TABLET;ORAL 011045-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc WAMPOCAP niacin CAPSULE;ORAL 011073-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc MILTOWN meprobamate TABLET;ORAL 009698-004 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Medpointe Pharm Hlc UNITENSEN cryptenamine tannates TABLET;ORAL 009217-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc NEOPASALATE aminosalicylate sodium; aminosalicylic acid TABLET;ORAL 080059-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-001 Dec 28, 1990 RE30577   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990 RE30577   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-002 Dec 28, 1990 RE30577   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Colorcon
Harvard Business School
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.